BSX
BOSTON SCIENTIFIC CORP
$48.70
+0.31%
$72.8B
No data for this timeframe.
Vol
Market Cap$72.8B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders11 funds
Inst. Value$31.2B
Inst. Activity3 buys / 1 sells
Insider Activity4B / 0S
Insider Net $$554.0K
Reddit Sentiment57° Neutral
SEC Reports5
Congressional6 trades
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000885725·Prev Close $48.55
Recent Activity
May 28, 2026
Insider
Mahoney Michael F sold 386,755 shares
Chairman, President & CEO @ $0.00 ($0.00)
May 21, 2026
SEC
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a cluster of insider buyi
CLUSTER — Impact 3/10
May 20, 2026
Insider
Habiger David C bought 2,250 shares
Director @ $55.92 ($125.8K)
May 20, 2026
Insider
Pegus Cheryl bought 1,770 shares
Director @ $56.49 ($100.0K)
May 18, 2026
SEC
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to repurchase its common
8-K — Impact 4/10
May 18, 2026
SEC
Boston Scientific invested $1.5 billion for a 33.75% equity stake in MiRus LLC, a privately-held developer of the SIEGEL
8-K — Impact 7/10
Inst.
BANK OF AMERICA CORP — TRIM
25,115,185 shares ($2.4B)
Inst.
NORGES BANK — NEW
23,066,546 shares ($2.2B)
Price Targets
$78.17
+59.7% upside
Strong Buy
Current $48.96
Low $55.00
Median $76.50
High $106.00
30 analysts
$55.00
$106.00
Analyst Ratings
12Strong Buy
20Buy
8Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 4, 2026 | Truist Securities | MAINTAIN | Buy → Buy |
| Jun 3, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 29, 2026 | Wolfe Research | DOWNGRADE | Outperform → Peer Perform |
| May 28, 2026 | Citigroup | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.83 | $0.81 — $0.84 | 11% YoY | 24 |
| Next Q | $0.84 ▼ -0.5% | $0.82 — $0.87 | 12% YoY | 23 |
| Current FY | $3.37 | $3.32 — $3.42 | 10% YoY | 28 |
| Next FY | $3.73 ▼ -0.9% | $3.65 — $3.90 | 11% YoY | 29 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a cluster of insider buyi
May 21, 2026
NEUTRAL
8-K
4/10
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to repurchase its common
May 18, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $13.3B | — |
| FMR LLC | $9.3B | — |
| BANK OF AMERICA CORP | $2.4B | TRIM |
| NORGES BANK | $2.2B | NEW |
| MORGAN STANLEY | $2.2B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | Mahoney Michael | G | $0.00 |
| May 20, 2026 | Habiger David | BUY | $125.8K |
| May 20, 2026 | Pegus Cheryl | BUY | $100.0K |
| May 20, 2026 | LUDWIG EDWARD | BUY | $202.9K |
| May 19, 2026 | Habiger David | BUY | $125.3K |
Reddit Sentiment
57°
Neutral
Bearish
Neutral
Bullish
Congressional Trades
5 members: 5 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Ro Khanna | D | BUY | $15,001 - $50,000 |
| Michael McCaul | R | BUY | $1,001 - $15,000 |
| Gilbert Cisneros | D | BUY | $1,001 - $15,000 |
11 institutional holders with $31.2B total value (326,809,489 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, BANK. Net buying activity: 3 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 139,685,997 | $13.3B | 42.7% | — |
| 2 | FMR LLC | 97,386,941 | $9.3B | 29.8% | — |
| 3 | BANK OF AMERICA CORP /DE/ | 25,115,185 | $2.4B | 7.7% | TRIM -28.8% |
| 4 | NORGES BANK | 23,066,546 | $2.2B | 7.1% | NEW |
| 5 | MORGAN STANLEY | 22,960,556 | $2.2B | 7.0% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8,946,503 | $853.0M | 2.7% | NEW |
| 7 | WELLS FARGO & COMPANY/MN | 4,654,828 | $443.8M | 1.4% | — |
| 8 | TWO SIGMA INVESTMENTS, LP | 2,475,144 | $236.0M | 0.8% | DOUBLED +229.0% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 2,382,705 | $227.2M | 0.7% | DOUBLED +159.8% |
| 10 | DODGE & COX | 88,885 | $8.5M | 0.0% | — |
| 11 | Mawer Investment Management Ltd. | 46,199 | $4.4M | 0.0% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | TRIM | 35,270,341 | 25,115,185 | -28.8% | $2.4B | 2025-Q4 |
| NORGES BANK | NEW | — | 23,066,546 | — | $2.2B | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 917,105 | 2,382,705 | +159.8% | $227.2M | 2025-Q4 |
| Mawer Investment Management Ltd. | NEW | — | 46,199 | — | $4.4M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 1,496,541 | 917,105 | -38.7% | $89.5M | 2025-Q3 |
| NORGES BANK | EXIT | 19,457,562 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 19,457,562 | — | $2.1B | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 651,553 | 1,496,541 | +129.7% | $160.7M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 741,847 | 2,440,747 | +229.0% | $246.2M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 651,553 | — | $65.7M | 2025-Q1 |
| NORGES BANK | EXIT | 19,732,673 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 10,671,703 | 5,950,952 | -44.2% | $531.5M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 258,025 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 8,018,377 | — | $671.9M | 2024-Q3 |
17 unique insiders with 4 transactions. Net insider value: $554.0K ($554.0K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | Mahoney Michael F | Chairman, President & CEO | G | 386,755 | $0.00 | $0.00 |
| May 20, 2026 | Habiger David C | Director | BUY | 2,250 | $55.92 | $125.8K |
| May 20, 2026 | Pegus Cheryl | Director | BUY | 1,770 | $56.49 | $100.0K |
| May 20, 2026 | LUDWIG EDWARD J | Director | BUY | 3,580 | $56.68 | $202.9K |
| May 19, 2026 | Habiger David C | Director | BUY | 2,200 | $56.95 | $125.3K |
| May 7, 2026 | LUDWIG EDWARD J | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Habiger David C | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Pegus Cheryl | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Mega Jessica L | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Morano Susan E | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Zane Ellen M | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | WICHMANN DAVID S | Director | A | 3,800 | $0.00 | $0.00 |
| May 7, 2026 | Weber Christophe Pierre | Director | A | 1,767 | $0.00 | $0.00 |
| May 7, 2026 | Weber Christophe Pierre | Director | A | 2,660 | $0.00 | $0.00 |
| May 7, 2026 | Smith Cathy R | Director | A | 3,800 | $0.00 | $0.00 |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | 2,102 | $0.00 | $0.00 |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | 2,102 | $0.00 | $0.00 |
| May 2, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | 1,007 | $56.50 | $56.9K |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,802 | $0.00 | $0.00 |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | F | 872 | $56.50 | $49.3K |
| May 2, 2026 | O'Connor Padraig Andrew | EVP, Global Operations | M | 1,802 | $0.00 | $0.00 |
| Mar 2, 2026 | Morano Susan E | Director | A | 24 | $0.00 | $0.00 |
| Mar 2, 2026 | Pegus Cheryl | Director | A | 24 | $0.00 | $0.00 |
| Mar 2, 2026 | Weber Christophe Pierre | Director | A | 556 | $0.00 | $0.00 |
| Mar 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | 838 | $0.00 | $0.00 |
| Mar 1, 2026 | Woodworth Emily | SVP, Global Controller and CAO | M | 838 | $0.00 | $0.00 |
| Feb 19, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | I | 6,851 | $75.76 | $519.0K |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | A | 11,143 | $0.00 | $0.00 |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | A | 4,722 | $0.00 | $0.00 |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | 961 | $0.00 | $0.00 |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | F | 338 | $74.12 | $25.1K |
| Feb 12, 2026 | O'Sullivan Miriam | SVP, Chief HR Officer | M | 961 | $0.00 | $0.00 |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | 35,817 | $0.00 | $0.00 |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | A | 15,178 | $0.00 | $0.00 |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | 2,692 | $0.00 | $0.00 |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | F | 1,302 | $74.12 | $96.5K |
| Feb 12, 2026 | Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC | M | 2,692 | $0.00 | $0.00 |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | 17,510 | $0.00 | $0.00 |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | A | 7,420 | $0.00 | $0.00 |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | 1,442 | $0.00 | $0.00 |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | F | 488 | $74.12 | $36.2K |
| Feb 12, 2026 | Brown Vance R | EVP, GC and Corp. Secretary | M | 1,442 | $0.00 | $0.00 |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | 43,776 | $0.00 | $0.00 |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | 18,550 | $0.00 | $0.00 |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | 3,462 | $0.00 | $0.00 |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | 1,612 | $74.12 | $119.5K |
| Feb 12, 2026 | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | 3,462 | $0.00 | $0.00 |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | A | 27,857 | $0.00 | $0.00 |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | A | 11,805 | $0.00 | $0.00 |
| Feb 12, 2026 | Monson Jonathan | EVP and CFO | M | 1,154 | $0.00 | $0.00 |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.8/10.
NEUTRAL
CLUSTER
3/10
Three directors purchased ~$554K of BSX stock in open-market transactions over two days. While a clu
May 21, 2026
NEUTRAL
8-K
4/10
Boston Scientific entered into a $2B accelerated share repurchase (ASR) agreement with JPMorgan to r
May 18, 2026
BULLISH
8-K
7/10
Boston Scientific invested $1.5 billion for a 33.75% equity stake in MiRus LLC, a privately-held dev
May 18, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable. This DEFA14A filing by Bo
Mar 18, 2026
BULLISH
INST-CLUSTER
7/10
Three major institutions — Norges Bank, Mawer Investment Management, and Renaissance Technologies —
Feb 28, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 40 analysts: 12 strong buy, 20 buy, 8 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$78.17 mean target
+59.7% upside
Strong Buy (1.48)
$55.00 Low
$106.00 High
| Metric | Value |
|---|---|
| Current Price | $48.96 |
| Target Low | $55.00 |
| Target Mean | $78.17 |
| Target Median | $76.50 |
| Target High | $106.00 |
| # Analysts | 30 |
| Recommendation | Strong Buy (1.48) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.83 | $0.81 | $0.84 | 10.6% | -0.3% | 1↑ 7↓ | $5.4B | 6.2% | 24 |
| Next Q 2026-09-30 |
$0.84 | $0.82 | $0.87 | 12.1% | -0.5% | 1↑ 9↓ | $5.4B | 6.3% | 23 |
| Current FY 2026-12-31 |
$3.37 | $3.32 | $3.42 | 10.0% | -0.3% | 1↑ 13↓ | $21.6B | 7.6% | 28 |
| Next FY 2027-12-31 |
$3.73 | $3.65 | $3.90 | 10.7% | -0.9% | 1↑ 11↓ | $23.4B | 8.3% | 29 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.830 | |
| 7d ago | $0.830 | -0.001 |
| 30d ago | $0.832 | -0.003 |
| 60d ago | $0.864 | -0.035 |
| 90d ago | $0.867 | -0.038 |
22 analyst firms have rated this stock: 0 upgrades, 3 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 4, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Jun 3, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jun 1, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 29, 2026 | Wolfe Research | DOWNGRADE | Outperform | Peer Perform |
| May 28, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| May 28, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| May 28, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| May 28, 2026 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| May 19, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| May 18, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| May 18, 2026 | Needham | REITERATE | Buy | Buy |
| May 18, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 23, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 23, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 23, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 23, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 22, 2026 | Jefferies | MAINTAIN | Buy | Buy |
| Apr 22, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 22, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 21, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Apr 15, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 13, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Apr 7, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 30, 2026 | RBC Capital | REITERATE | Outperform | Outperform |
| Mar 30, 2026 | Raymond James | DOWNGRADE | Strong Buy | Outperform |
| Mar 30, 2026 | Needham | REITERATE | Buy | Buy |
| Mar 27, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Mar 20, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Mar 20, 2026 | Needham | REITERATE | Buy | Buy |
| Mar 18, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Mar 17, 2026 | UBS | MAINTAIN | Buy | Buy |
| Mar 11, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 17, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 5, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | UBS | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Feb 5, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | Morgan Stanley | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | Stifel | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 12 | 20 | 8 | 0 | 0 | 80% | |
| May 1, 2026 | 13 | 23 | 5 | 0 | 0 | 88% | |
| Apr 1, 2026 | 13 | 25 | 3 | 0 | 0 | 93% | |
| Mar 1, 2026 | 14 | 23 | 3 | 0 | 0 | 93% | |
| Feb 1, 2026 | 15 | 22 | 3 | 0 | 0 | 93% | |
| Jan 1, 2026 | 15 | 21 | 4 | 0 | 0 | 90% |
Strong BuyBuyHoldSellStrong Sell
5 members of Congress traded this stock: 5 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Ro Khanna | D | HOUSE | BUY | $15,001 - $50,000 | Boston Scientific Corp | Apr 9, 2026 (11d) |
| Mar 27, 2026 | Michael McCaul | R | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Apr 10, 2026 (15d) |
| Feb 10, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Mar 10, 2026 (29d) |
| Jan 30, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | Boston Scientific Corp | Feb 16, 2026 (18d) |
| Dec 29, 2025 | Markwayne Mullin | R | SENATE | BUY | $15,001 - $50,000 | Boston Scientific Corp | Jan 16, 2026 (19d) |
| Dec 17, 2025 | John Boozman | R | SENATE | SELL | $1,001 - $15,000 | Boston Scientific Corp | Jan 13, 2026 (28d) |
57°
Neutral
Bearish
Neutral
Bullish
3 mentions
2 bullish
1 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 28, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Will Medtronic be punished like BSX was?
▲ 1
💬 1
⚡ 0.5
May 18, 2026
dark_pool
Dark Pool: BSX — 18.3M shares, 197,075 trades
Week starting 2026-05-18. Total ATS volume: 18,257,221 shares across 197,075 trades.
May 13, 2026
short_interest
FTD: BSX — 21,439 shares ($1.2M) failed to deliver
Settlement: 20260513, Price: $54.10, FTD Value: $1,159,849.9, BOSTON SCIENTIFIC CORP
May 11, 2026
dark_pool
Dark Pool: BSX — 20.4M shares, 207,129 trades
Week starting 2026-05-11. Total ATS volume: 20,394,228 shares across 207,129 trades.
May 8, 2026
short_interest
FTD: BSX — 8,866 shares ($0.5M) failed to deliver
Settlement: 20260508, Price: $56.57, FTD Value: $501,549.62, BOSTON SCIENTIFIC CORP
May 5, 2026
short_interest
FTD: BSX — 39,690 shares ($2.3M) failed to deliver
Settlement: 20260505, Price: $56.85, FTD Value: $2,256,376.5, BOSTON SCIENTIFIC CORP
May 4, 2026
dark_pool
Dark Pool: BSX — 23.9M shares, 211,526 trades
Week starting 2026-05-04. Total ATS volume: 23,891,732 shares across 211,526 trades.
May 1, 2026
short_interest
FTD: BSX — 177,348 shares ($10.2M) failed to deliver
Settlement: 20260501, Price: $57.61, FTD Value: $10,217,018.28, BOSTON SCIENTIFIC CORP
Apr 27, 2026
dark_pool
Dark Pool: BSX — 24.3M shares, 229,523 trades
Week starting 2026-04-27. Total ATS volume: 24,279,150 shares across 229,523 trades.
Apr 22, 2026
earnings_calendar
BSX Q1 2026 Earnings Before Market Open — 2026-04-22
Apr 20, 2026
dark_pool
Dark Pool: BSX — 38.6M shares, 325,556 trades
Week starting 2026-04-20. Total ATS volume: 38,597,185 shares across 325,556 trades.
Apr 20, 2026
short_interest
FTD: BSX — 24,279 shares ($1.6M) failed to deliver
Settlement: 20260420, Price: $64.23, FTD Value: $1,559,440.17, BOSTON SCIENTIFIC CORP
Apr 13, 2026
dark_pool
Dark Pool: BSX — 14.9M shares, 149,938 trades
Week starting 2026-04-13. Total ATS volume: 14,941,332 shares across 149,938 trades.
Apr 6, 2026
dark_pool
Dark Pool: BSX — 21.4M shares, 184,925 trades
Week starting 2026-04-06. Total ATS volume: 21,416,259 shares across 184,925 trades.
Mar 30, 2026
dark_pool
Dark Pool: BSX — 32.2M shares, 278,600 trades
Week starting 2026-03-30. Total ATS volume: 32,155,827 shares across 278,600 trades.
Mar 23, 2026
dark_pool
Dark Pool: BSX — 16.0M shares, 181,662 trades
Week starting 2026-03-23. Total ATS volume: 15,984,247 shares across 181,662 trades.